Literature DB >> 28694291

Differential Regulation of Mas-Related G Protein-Coupled Receptor X2-Mediated Mast Cell Degranulation by Antimicrobial Host Defense Peptides and Porphyromonas gingivalis Lipopolysaccharide.

Kshitij Gupta1, Chizobam Idahosa2, Saptarshi Roy1, Donguk Lee1, Hariharan Subramanian1, Anuradha Dhingra3, Kathleen Boesze-Battaglia3, Jonathan Korostoff4, Hydar Ali5.   

Abstract

Porphyromonas gingivalis is a keystone pathogen that contributes to periodontal pathogenesis by disrupting host-microbe homeostasis and promoting dysbiosis. The virulence of P. gingivalis likely reflects an alteration in the lipid A composition of its lipopolysaccharide (LPS) from the penta-acylated (PgLPS1690) to the tetra-acylated (PgLPS1435/1449) form. Mast cells play an important role in periodontitis, but the mechanisms of their activation and regulation remain unknown. The expression of epithelium- and neutrophil-derived host defense peptides (HDPs) (LL-37 and human β-defensin-3), which activate mast cells via Mas-related G protein-coupled receptor X2 (MRGPRX2), is increased in periodontitis. We found that MRGPRX2-expressing mast cells are present in normal gingiva and that their numbers are elevated in patients with chronic periodontitis. Furthermore, HDPs stimulated degranulation in a human mast cell line (LAD2) and in RBL-2H3 cells stably expressing MRGPRX2 (RBL-MRGPRX2). PgLPS1690 caused substantial inhibition of HDP-induced mast cell degranulation, but PgLPS1435/1449 had no effect. A fluorescently labeled HDP (FAM-LL-37) bound to RBL-MRGPRX2 cells, and PgLPS1690 inhibited this binding, but PgLPS1435/1449 had no effect. These findings suggest that low-level inflammation induced by HDP/MRGPRX2-mediated mast cell degranulation contributes to gingival homeostasis but that sustained inflammation due to elevated levels of both HDPs and MRGPRX2-expressing mast cells promotes periodontal disease. Furthermore, differential regulation of HDP-induced mast cell degranulation by PgLPS1690 and PgLPS1435/1449 may contribute to the modulation of disease progression.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  Porphyromonas gingivalis; antimicrobial peptides; host response; lipopolysaccharide; mast cell; periodontal immunology

Mesh:

Substances:

Year:  2017        PMID: 28694291      PMCID: PMC5607414          DOI: 10.1128/IAI.00246-17

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  77 in total

1.  Immunoglobulin E-independent activation of mast cell is mediated by Mrg receptors.

Authors:  Kazuhiko Tatemoto; Yuko Nozaki; Ryoko Tsuda; Shinobu Konno; Keiko Tomura; Masahiro Furuno; Hiroyuki Ogasawara; Koji Edamura; Hideo Takagi; Hiroyuki Iwamura; Masato Noguchi; Takayuki Naito
Journal:  Biochem Biophys Res Commun       Date:  2006-09-08       Impact factor: 3.575

2.  Antagonistic lipopolysaccharides block E. coli lipopolysaccharide function at human TLR4 via interaction with the human MD-2 lipopolysaccharide binding site.

Authors:  Stephen R Coats; Christopher T Do; Lisa M Karimi-Naser; Pamela H Braham; Richard P Darveau
Journal:  Cell Microbiol       Date:  2007-01-09       Impact factor: 3.715

3.  PMX-53 as a dual CD88 antagonist and an agonist for Mas-related gene 2 (MrgX2) in human mast cells.

Authors:  Hariharan Subramanian; Sakeen W Kashem; Sarah J Collington; Hongchang Qu; John D Lambris; Hydar Ali
Journal:  Mol Pharmacol       Date:  2011-03-11       Impact factor: 4.436

Review 4.  Breaking bad: manipulation of the host response by Porphyromonas gingivalis.

Authors:  George Hajishengallis; Richard J Lamont
Journal:  Eur J Immunol       Date:  2014-02       Impact factor: 5.532

5.  Mast cell degranulation in human periodontitis.

Authors:  Shiguang Huang; Fangli Lu; Ying Chen; Bo Huang; Man Liu
Journal:  J Periodontol       Date:  2012-04-17       Impact factor: 6.993

6.  Distinct regulation of C3a-induced MCP-1/CCL2 and RANTES/CCL5 production in human mast cells by extracellular signal regulated kinase and PI3 kinase.

Authors:  Rampura T Venkatesha; E Berla Thangam; Asifa K Zaidi; Hydar Ali
Journal:  Mol Immunol       Date:  2005-03       Impact factor: 4.407

7.  Epithelial cell-derived human beta-defensin-2 acts as a chemotaxin for mast cells through a pertussis toxin-sensitive and phospholipase C-dependent pathway.

Authors:  François Niyonsaba; Kazuhisa Iwabuchi; Hiroshi Matsuda; Hideoki Ogawa; Isao Nagaoka
Journal:  Int Immunol       Date:  2002-04       Impact factor: 4.823

8.  Mast Cells Contribute to Porphyromonas gingivalis-induced Bone Loss.

Authors:  J Malcolm; O Millington; E Millhouse; L Campbell; A Adrados Planell; J P Butcher; C Lawrence; K Ross; G Ramage; I B McInnes; S Culshaw
Journal:  J Dent Res       Date:  2016-03-01       Impact factor: 6.116

9.  Deficiency of the tryptase-positive, chymase-negative mast cell type in gastrointestinal mucosa of patients with defective T lymphocyte function.

Authors:  A M Irani; S S Craig; G DeBlois; C O Elson; N M Schechter; L B Schwartz
Journal:  J Immunol       Date:  1987-06-15       Impact factor: 5.422

10.  beta-Defensins chemoattract macrophages and mast cells but not lymphocytes and dendritic cells: CCR6 is not involved.

Authors:  Afsaneh Soruri; Jasmin Grigat; Ulf Forssmann; Joachim Riggert; Jörg Zwirner
Journal:  Eur J Immunol       Date:  2007-09       Impact factor: 5.532

View more
  10 in total

1.  Naturally Occurring Missense MRGPRX2 Variants Display Loss of Function Phenotype for Mast Cell Degranulation in Response to Substance P, Hemokinin-1, Human β-Defensin-3, and Icatibant.

Authors:  Ibrahim Alkanfari; Kshitij Gupta; Tahsin Jahan; Hydar Ali
Journal:  J Immunol       Date:  2018-05-23       Impact factor: 5.422

Review 2.  Multifaceted MRGPRX2: New insight into the role of mast cells in health and disease.

Authors:  Saptarshi Roy; Chalatip Chompunud Na Ayudhya; Monica Thapaliya; Vishwa Deepak; Hydar Ali
Journal:  J Allergy Clin Immunol       Date:  2021-05-04       Impact factor: 14.290

3.  Upregulation of Mas-related G Protein coupled receptor X2 in asthmatic lung mast cells and its activation by the novel neuropeptide hemokinin-1.

Authors:  Wichayapha Manorak; Chizobam Idahosa; Kshitij Gupta; Saptarshi Roy; Reynold Panettieri; Hydar Ali
Journal:  Respir Res       Date:  2018-01-03

4.  IL-33 and MRGPRX2-Triggered Activation of Human Skin Mast Cells-Elimination of Receptor Expression on Chronic Exposure, but Reinforced Degranulation on Acute Priming.

Authors:  Zhao Wang; Sven Guhl; Kristin Franke; Metin Artuc; Torsten Zuberbier; Magda Babina
Journal:  Cells       Date:  2019-04-11       Impact factor: 6.600

5.  Small-Molecule Host-Defense Peptide Mimetic Antibacterial and Antifungal Agents Activate Human and Mouse Mast Cells via Mas-Related GPCRs.

Authors:  Ibrahim Alkanfari; Katie B Freeman; Saptarshi Roy; Tahsin Jahan; Richard W Scott; Hydar Ali
Journal:  Cells       Date:  2019-04-03       Impact factor: 6.600

Review 6.  Mast Cells as Potential Accelerators of Human Atherosclerosis-From Early to Late Lesions.

Authors:  Petri T Kovanen
Journal:  Int J Mol Sci       Date:  2019-09-11       Impact factor: 5.923

Review 7.  The Multifaceted Mas-Related G Protein-Coupled Receptor Member X2 in Allergic Diseases and Beyond.

Authors:  Paola Leonor Quan; Marina Sabaté-Brescó; Yanru Guo; Margarita Martín; Gabriel Gastaminza
Journal:  Int J Mol Sci       Date:  2021-04-23       Impact factor: 5.923

Review 8.  Inflammatory Cells in Atherosclerosis.

Authors:  Marcelle Mehu; Chandrakala Aluganti Narasimhulu; Dinender K Singla
Journal:  Antioxidants (Basel)       Date:  2022-01-26

9.  Identification of nine signature proteins involved in periodontitis by integrated analysis of TMT proteomics and transcriptomics.

Authors:  Wei Liu; Wei Qiu; Zhendong Huang; Kaiying Zhang; Keke Wu; Ke Deng; Yuanting Chen; Ruiming Guo; Buling Wu; Ting Chen; Fuchun Fang
Journal:  Front Immunol       Date:  2022-08-09       Impact factor: 8.786

10.  Roles of a Mast Cell-Specific Receptor MRGPRX2 in Host Defense and Inflammation.

Authors:  C Chompunud Na Ayudhya; S Roy; M Thapaliya; H Ali
Journal:  J Dent Res       Date:  2020-05-11       Impact factor: 8.924

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.